The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
Should You Forget Nvidia and Buy 2 Artificial Intelligence (AI) Stocks Instead? Nvidia stock has been weighed down by factors outside its control in recent months, which is why investors could look at these two stocks to capitalize on AI adoption.
Prediction: This Artificial Intelligence (AI) Stock Will Benefit Most From the Shift to Software Monetization in 2026 Microsoft's expanding Copilot ecosystem and enterprise software reach will make it one of the biggest beneficiaries of artificial intelligence (AI) software monetization in 2026.
Palantir vs. Amazon: Which AI Stock Is a Better Buy Now? Both tech companies are posting impressive growth thanks to artificial intelligence, but one of the two stocks looks far more attractive than the other.
Growth Stocks Are Getting Riskier. This ETF Historically Holds Up Better Growth stocks are facing a much different environment than the one they enjoyed the past few years. It's time to look at defensive alternatives.
ISCG vs. RZG: Which Small-Cap Growth ETF Fits Your Portfolio? Expense ratios, sector tilts, and portfolio breadth set these two small-cap growth ETFs apart for investors weighing their options.
Is Vertex Pharmaceuticals Heading to $600? A new product approval may be right around the corner.
Better Nuclear Energy Stock: Oklo vs. Centrus Energy The two nuclear energy companies are in the early stages of discussing a joint venture to develop next-generation nuclear fuel, but one looks like a better buy today.
CBIZ Insider Sale: Trust Move or Warning Sign? CBIZ, Inc., a major business services provider, reported significant insider selling amid a year of sharp share price declines.
Battle of the Tech ETFs: How IYW and XLK Compare on Risk, Fees, and Performance Explore how differences in cost, diversification, and risk set these two tech ETFs apart for investors seeking tailored sector exposure.
Maxed Out Your IRA? Here's What to Do Next. You have a number of options if you're looking to save more.
The Best Stocks to Invest $1,000 in Right Now Given the market's uncertainty, now is a good time to err on the side of caution... and dividends.
IMAX CEO Sold Shares Worth $4.9 Million. Is the Stock a Buy or Sell? IMAX, a global leader in premium cinema technology, reported significant insider selling amid a year of strong stock performance.
Infrastructure Stock Up 67% This Past Year Just Drew a New $6 Million Investment This infrastructure contractor delivers large-scale civil projects and materials for public and private clients across the U.S.
SPXL vs. TQQQ: Is S&P 500 Stability or Tech-Focused Growth the Better Buy for Leveraged ETF Investors? Explore how sector exposure and risk profiles set these leveraged ETFs apart for traders seeking distinct portfolio dynamics.
Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year This water solutions provider serves both consumers and businesses through recurring sales and a broad portfolio of regional brands.
Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue Euronet Worldwide runs a global payments platform, providing transaction processing and money transfer solutions across diverse markets.
Is Signet Jewelers Seriously Undervalued? Shares of Signet Jewelers are up over 70% over the past year, limiting the value appeal of the stock as economic concerns hit consumers.
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment EyePoint develops sustained-release treatments for retinal diseases, leveraging proprietary technology and strategic industry partnerships.
This Fund Built a $26 Million Stake in a Medical Tech Stock That's Soaring After a $9.9 Billion Deal Announcement This medical technology firm delivers advanced noninvasive monitoring and automation solutions to healthcare providers worldwide.
This Community Bank With $9 Billion in Assets Just Drew a $2.5 Million Investor Buy Origin Bancorp delivers banking, lending, and financial services to businesses and consumers across Texas, Louisiana, and Mississippi.
Regional Bank Stock Up 14% in a Year as Investor Sells $2.6 Million in Shares UMB Financial provides diversified banking and asset management services across 15 states, generating revenue from interest and fees.
This Investor Sold $5 Million of a Biotech Stock Up 118% in a Year, but Here's Why It Still Seems Bullish on Shares This biotech firm develops therapies targeting cystic fibrosis, with shares up nearly 90% year-over-year as of the latest filing.
This Investor Built a $56 Million Position in RAPT Last Quarter. It Was Just Acquired for $58 Per Share RAPT Therapeutics develops oral therapies for cancer and inflammation, with key drug candidates currently in clinical trials.
Offshore Driller With $7.5 Billion Backlog Sees $6 Million Investor Trim Amid Staggering Stock Surge Specializing in offshore drilling, Noble Corporation serves global oil and gas clients with a modern fleet and steady dividend yield.
Telecom Stock Up 25% Over the Past Year Draws $21 Million Bet From Hedge Fund This telecom provider delivers wireless, broadband, and IoT solutions nationwide, serving both consumer and business markets.
Fidelity (FDVV) vs. ProShares (NOBL): Which Dividend ETF Reigns Supreme? Explore how sector tilts, yield focus, and portfolio strategy set these dividend ETFs apart for income-minded investors.
Should You Buy Micron Before Earnings? Here's the 1 Thing That Matters. With Micron's earnings report approaching fast, investors should watch for memory supply demand trends.
Is a Sub-6% Mortgage Rate Enough to Make Buying in Retirement Worth It? At one time, a sub-6% mortgage would have seemed like a miracle. Today, it just raises questions about buying a home versus investing.
Hedge Fund Boone Capital Initiated a Stake in HealthEquity. Is the Stock a Buy? HealthEquity delivers cloud-based healthcare savings solutions to employers and individuals, with a broad client network across the U.S.
Is American Express Stock a Millionaire Maker? Shares of the premium credit card business have tanked 18% in 2026.
2 No-Brainer AI Stocks to Buy Right Now Broadcom and Meta Platforms look like two solid AI stocks to buy right now.
A Healthcare Hedge Fund Just Added $24.5 Million in Immunovant Stock. Should you? This clinical-stage biotech develops antibody therapies targeting autoimmune diseases, with a lead candidate in Phase II trials.
$100 Invested in This Semiconductor Stock Today Could Be Worth $200 by 2030 This semiconductor company's improving prospects are likely to send the stock soaring through the end of the decade.
Did Warren Buffett Know Something Wall Street Doesn't? The Former Berkshire Hathaway CEO Left a $373 Billion Warning for the Stock Market. Warren Buffett left Berkshire Hathaway with a massive war chest and spent his final years as CEO selling stocks while Wall Street celebrated record highs.
The Fastest Stock That Could Unlock Investor Riches ... Slowly This brand has built its well-known global image on the efforts of its racing team and pure speed. But its stock will help investors build wealth slowly, consistently, and more safely than traditional autos.
Better Stock to Buy Right Now: Dutch Bros vs. Starbucks Dutch Bros and Starbucks are forging different paths to dominate the coffee market.
Better Cryptocurrency to Buy With $2,000 and Hold for a Decade: XRP vs. Solana The next 10 years will see these coins either succeed or fail to fulfill their ambitions.
My Top 5 AI Stocks to Buy Amid the Market Pullback These are fantastic stocks to hold throughout the AI boom.
3 Stocks Investors Should Buy Hand Over Fist The market is handing investors some incredible deals right now.
My Top Growth Stock to Buy for 2026 (and It's Not Even Close) This company is getting into AI and has several exciting growth catalysts on the way.
Oracle Has Fallen 18% in 2026. Wall Street's Top Pick Just Set a $210 Price Target. Oracle's stock has plummeted since hitting a high of $345 in September 2025. Will a record quarter quell fears?
1 Top Growth Stock Turned $10,000 Into $423,000 -- It's Still a Buy Now Some investors shy away after big gains, thinking the opportunity was missed. That's certainly not the case with this high-flying stock.
3 Reasons Why Bittensor Skyrocketed More than 56% This Week Bittensor is absolutely taking off right now. Here's what's behind the rise in this top-30 token.
Meet the Monster Stock That Continues to Crush the Market Artificial intelligence (AI) semiconductor stocks have largely outperformed the S&P 500 over the last few years.
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term These consumer goods growth stocks look poised to beat the S&P 500 in the long run.
My Top 3 Cryptocurrencies to Buy for the Next Bull Run Bitcoin, Ether, and Solana are all worth buying before the bulls return.
1 Artificial Intelligence (AI) Stock I'd Never Sell After flirting with bankruptcy just over a decade ago, AMD has risen to be the No. 2 company in the AI accelerator market.
2 Monster Energy Stocks to Hold for the Next 10 Years Vistra and Constellation Energy provide the green power to enable hyperscalers to grow.
VONG or SPYM: Which Stock ETF Is a Better Buy? VONG is a low-cost tech-heavy U.S. stock index fund -- but if you're wary of too much tech in your portfolio, SPYM could be better.
NICE Stock Fell Over 20% Last Quarter. One Investor Exited a $3 Million Position This cloud software provider delivers AI-driven platforms for customer engagement, compliance, and automation to global enterprises.
This Investor Is Betting $16 Million on a Software Stock Down 17% This Past Year. Here's What to Know Specializing in AI-powered cloud platforms, NICE delivers enterprise solutions for customer experience, analytics, and compliance worldwide.
Better Buy Right Now With $1,500: Bitcoin vs. an Index Fund There are strong arguments in favor of owning both of these assets.
Waystar Stock Is Down 32% This Past Year, but One Fund Bought Up $11.5 Million Last Quarter Waystar delivers cloud-based software to streamline healthcare payments and revenue cycle management for providers nationwide.
Prediction: Buying Ethereum Today Could Set You Up for Life The world's second-most-valuable cryptocurrency has a bright future.
